Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Recent findings indicate that widely used weight-loss medications might lead to muscle loss, including vital heart muscle, ...

A woman who lost 64 pounds on a compounded form of the weight loss drug semaglutide, marketed as Wegovy and Ozempic, started ...

Developed initially to manage diabetes, glucagon-like peptide-1 (GLP-1) receptor agonists have skyrocketed in popularity ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

Frozen’s Josh Gad shared insight into his weight loss journey after losing 40 pounds with the help of medication.

A new study conducted by researchers from the University of Eastern Finland the Karolinska Institutet explored the ways that ...

While semaglutide is still on the shortage list, the FDA is expected to eventually end that designation, and compounders will ...

Research identifies key factors affecting semaglutide initiation among obese individuals without diabetes, revealing ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

In the logistic regression model of the top 20 factors, significant associations for semaglutide initiation included being female (adjusted odds ratio, 2.30), using certain medication classes ...

Health Canada has issued a recall notice for compounded drugs containing semaglutide, which is a key component in popular ...